United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports $5.13 Million Common Share Sale
Bitget2026/10/15 20:36- United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 shares of common stock on Oct. 14, 2026.
- She exercised 9,500 stock options at $117.76 per share, leaving 233,410 options held indirectly through a trust.
- Sale prices ranged from $526.07 to $546 per share. The transactions left 324,443 common shares in the transacting trusts.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Susquehanna raises pre-earnings price targets for chip stocks: AMD (AMD.US), Qualcomm (QCOM.US), etc. receive upward revisions
Susquehanna has adjusted the target prices for chip stocks such as AMD, Intel, and Qualcomm.
Wedbush: Hard drive supply falls short of demand, Seagate (STX.US) and Western Digital (WDC.US) earnings reports may bring surprises
Wedbush reiterated its "outperform" ratings for Seagate and Western Digital, setting target prices at $1,000 and $650, respectively.
JPMorgan maintains Underweight rating on Nike (NKE.US): Deep in adjustment pains, performance pressures may persist until fiscal year 2028
Recently, JPMorgan released a U.S. equity research report on Nike. The research team participated in a face-to-face meeting with Nike's new CFO, Denton, updated profit assumptions based on management statements, and maintained an “underweight” investment rating on Nike.
Crypto prices
More
